The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Efficient Killing of Human Colon Cancer Stem Cells by γδ T Lymphocytes
Abstract
Colon cancer comprises a small population of cancer stem cells (CSC) that is responsible for tumor maintenance and resistant to cancer therapies, possibly allowing for tumor recapitulation once treatment stops. We previously demonstrated that such chemoresistance is mediated by autocrine production of IL-4 through the up-regulation of antiapoptotic proteins. Several innate and adaptive immune effector cells allow for the recognition and destruction of cancer precursors before they constitute the tumor mass. However, cellular immune-based therapies have not been experimented yet in the population of CSCs. Here, we show that the bisphosphonate zoledronate sensitizes colon CSCs to Vγ9Vδ2 T cell cytotoxicity. Proliferation and production of cytokines (TNF-α and IFN-γ) and cytotoxic and apoptotic molecules (TRAIL and granzymes) were also induced after exposure of Vγ9Vδ2 T cells to sensitized targets. Vγ9Vδ2 T cell cytotoxicity was mediated by the granule exocytosis pathway and was highly dependent on isoprenoid production by of tumor cells. Moreover, CSCs recognition and killing was mainly TCR mediated, whereas NKG2D played a role only when tumor targets expressed several NKG2D ligands. We conclude that intentional activation of Vγ9Vδ2 T cells by zoledronate may substantially increase antitumor activities and represent a novel strategy for colon cancer immunotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Slamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441101 · Cited by 11,500
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagès, C., Tosolini, M., Camus, M., Berger, A., Wind, P., et al. (2006) · Science · doi:10.1126/science.1129139 · Cited by 6,516
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
O’Brien, C. A., Pollett, A., Gallinger, S., & Dick, J. E. (2007) · Nature · doi:10.1038/nature05372 · Cited by 4,087
Identification and expansion of human colon-cancer-initiating cells
Ricci-Vitiani, L., Lombardi, D. G., Pilozzi, E., Biffoni, M., Todaro, M., Peschle, C., & De Maria, R. (2007) · Nature · doi:10.1038/nature05384 · Cited by 3,998
Self-citationActivation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA
Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L., & Spies, T. (1999) · Science · doi:10.1126/science.285.5428.727 · Cited by 2,999
Direct isolation of human central nervous system stem cells
Uchida, N., Buck, D. W., He, D., Reitsma, M. J., Masek, M., Phan, T. V., Tsukamoto, A. S., Gage, F. H., & Weissman, I. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.26.14720 · Cited by 1,849
γδ Cells: A Right Time and a Right Place for a Conserved Third Way of Protection
Hayday, A. C. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.975 · Cited by 1,136
Colon Cancer Stem Cells Dictate Tumor Growth and Resist Cell Death by Production of Interleukin-4
Todaro, M., Alea, M. P., Di Stefano, A. B., Cammareri, P., Vermeulen, L., Iovino, F., Tripodo, C., Russo, A., Gulotta, G., Medema, J. P., et al. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.08.001 · Cited by 1,039
Self-citationSmyth, M. J., Dunn, G. P., & Schreiber, R. D. (2006) · Advances in Immunology · doi:10.1016/s0065-2776(06)90001-7 · Cited by 870
Human T Cell Receptor γδ Cells Recognize Endogenous Mevalonate Metabolites in Tumor Cells
Gober, H.-J., Kistowska, M., Angman, L., Jenö, P., Mori, L., & De Libero, G. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021500 · Cited by 847
Adoptive immunotherapy for cancer: building on success
Gattinoni, L., Powell, D. J., Rosenberg, S. A., & Restifo, N. P. (2006) · Nature Reviews Immunology · doi:10.1038/nri1842 · Cited by 845
Stimulation of Human γδ T Cells by Nonpeptidic Mycobacterial Ligands
Constant, P., Davodeau, F., Peyrat, M.-A., Poquet, Y., Puzo, G., Bonneville, M., & Fournié, J.-J. (1994) · Science · doi:10.1126/science.8146660 · Cited by 711
Immunotherapy and chemotherapy — a practical partnership
Lake, R. A., & Robinson, B. W. S. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1613 · Cited by 646
γδ T cells for immune therapy of patients with lymphoid malignancies
Wilhelm, M., Kunzmann, V., Eckstein, S., Reimer, P., Weissinger, F., Ruediger, T., & Tony, H.-P. (2003) · Blood · doi:10.1182/blood-2002-12-3665 · Cited by 550
Dieli, F., Vermijlen, D., Fulfaro, F., Caccamo, N., Meraviglia, S., Cicero, G., Roberts, A., Buccheri, S., D'Asaro, M., Gebbia, N., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0199 · Cited by 497
Self-citationMICA Engagement by Human Vγ2Vδ2 T Cells Enhances Their Antigen-Dependent Effector Function
Das, H., Groh, V., Kuijl, C., Sugita, M., Morita, C. T., Spies, T., & Bukowski, J. F. (2001) · Immunity · doi:10.1016/s1074-7613(01)00168-6 · Cited by 409 · cited 1×
“V 9V 2 T cell activity is tightly regulated by NK-like receptors for MHC class I ligands, and some previous studies have indicated the importance of NKG2D-MICA/B interactions for tumor cell recognition and cytotoxic activity by V 9V 2 T cells (53, 54).”
BackgroundGenetic Progression and the Waiting Time to Cancer
Beerenwinkel, N., Antal, T., Dingli, D., Traulsen, A., Kinzler, K. W., Velculescu, V. E., Vogelstein, B., & Nowak, M. A. (2007) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0030225 · Cited by 408
γ/δ T-Cell Stimulation by Pamidronate
Kunzmann, V., Bauer, E., & Wilhelm, M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903043400914 · Cited by 395
Self-Recognition of Cd1 by γ/δ T Cells
Spada, F. M., Grant, E. P., Peters, P. J., Sugita, M., Melián, A., Leslie, D. S., Lee, H. K., van Donselaar, E., Hanson, D. A., Krensky, A. M., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.6.937 · Cited by 378
Dieli, F., Poccia, F., Lipp, M., Sireci, G., Caccamo, N., Di Sano, C., & Salerno, A. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030235 · Cited by 322
Self-citationAntitumor effects of bisphosphonates
Green, J. R. (2003) · Cancer · doi:10.1002/cncr.11128 · Cited by 311
Gene mutations and altered gene expression in azoxymethane‐induced colon carcinogenesis in rodents
Takahashi, M., & Wakabayashi, K. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb03235.x · Cited by 304
Scotet, E., Martinez, L. O., Grant, E., Barbaras, R., Jenö, P., Guiraud, M., Monsarrat, B., Saulquin, X., Maillet, S., Estève, J.-P., et al. (2005) · Immunity · doi:10.1016/j.immuni.2004.11.012 · Cited by 298
Chien, Y.-H., Jores, R., & Crowley, M. P. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.511 · Cited by 283
Perspectives of γδ T Cells in Tumor Immunology
Kabelitz, D., Wesch, D., & He, W. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3069 · Cited by 251
Bennouna, J., Bompas, E., Neidhardt, E. M., Rolland, F., Philip, I., Galéa, C., Salot, S., Saiagh, S., Audrain, M., Rimbert, M., et al. (2008) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-008-0491-8 · Cited by 249
Feldman, E. J., Brandwein, J., Stone, R., Kalaycio, M., Moore, J., O'Connor, J., Wedel, N., Roboz, G. J., Miller, C., Chopra, R., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.133 · Cited by 249
Kobayashi, H., Tanaka, Y., Yagi, J., Osaka, Y., Nakazawa, H., Uchiyama, T., Minato, N., & Toma, H. (2007) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-006-0199-6 · Cited by 237
Apoptosis resistance in epithelial tumors is mediated by tumor-cell-derived interleukin-4
Todaro, M., Lombardo, Y., Francipane, M. G., Alea, M. P., Cammareri, P., Iovino, F., Di Stefano, A. B., Di Bernardo, C., Agrusa, A., Condorelli, G., et al. (2008) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402305 · Cited by 233
Self-citationBisphosphonates and Cancer-Induced Bone Disease: Beyond Their Antiresorptive Activity
Clézardin, P., Ebetino, F. H., & Fournier, P. G. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0264 · Cited by 232
Vγ9Vδ2 T Cell Response to Colon Carcinoma Cells
Corvaisier, M., Moreau-Aubry, A., Diez, E., Bennouna, J., Mosnier, J.-F., Scotet, E., Bonneville, M., & Jotereau, F. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.8.5481 · Cited by 207
Human Vγ9Vδ2 T cells: promising new leads for immunotherapy of infections and tumors
Bonneville, M., & Scotet, E. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2006.07.002 · Cited by 203
Phosphostim-Activated γδ T Cells Kill Autologous Metastatic Renal Cell Carcinoma
Viey, E., Fromont, G., Escudier, B., Morel, Y., Da Rocha, S., Chouaib, S., & Caignard, A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.3.1338 · Cited by 192
Vγ2Vδ2 T-cell receptor–mediated recognition of aminobisphosphonates
Das, H., Wang, L., Kamath, A., & Bukowski, J. F. (2001) · Blood · doi:10.1182/blood.v98.5.1616 · Cited by 178
Conticello, C., Pedini, F., Zeuner, A., Patti, M., Zerilli, M., Stassi, G., Messina, A., Peschle, C., & De Maria, R. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.9.5467 · Cited by 162
Self-citationChemotherapy and zoledronate sensitize solid tumour cells to Vγ9Vδ2 T cell cytotoxicity
Mattarollo, S. R., Kenna, T., Nieda, M., & Nicol, A. J. (2007) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-007-0279-2 · Cited by 160
Prokopchuk, O., Liu, Y., Henne-Bruns, D., & Kornmann, M. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602416 · Cited by 159
Targeting of Tumor Cells for Human γδ T Cells by Nonpeptide Antigens
Kato, Y., Tanaka, Y., Miyagawa, F., Yamashita, S., & Minato, N. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.9.5092 · Cited by 146
Stassi, G., Todaro, M., Zerilli, M., Ricci‐Vitiani, L., Liberto, D. D., Patti, M., Florena, A., Gaudio, F. D., Gesù, G. D., & Maria, R. D. (2003) · PubMed · Cited by 144
Self-citationTodaro, M., Zerilli, M., Ricci‐Vitiani, L., Bini, M., Alea, M. P., Florena, A. M., Miceli, L., Condorelli, G., Bonventre, S., Gesù, G. D., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2514 · Cited by 126
Self-citationFisch, P., Meuer, E., Pende, D., Rothenfußer, S., Viale, O., Kock, S., Ferrone, S., FRADELIZI, D., Klein, G., Moretta, L., et al. (1997) · European Journal of Immunology · doi:10.1002/eji.1830271236 · Cited by 125
Ponomarev, E. D., & Dittel, B. N. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.8.4678 · Cited by 123
Caccamo, N., Meraviglia, S., Ferlazzo, V., Angelini, D. F., Borsellino, G., Poccia, F., Battistini, L., Dieli, F., & Salerno, A. (2005) · European Journal of Immunology · doi:10.1002/eji.200525983 · Cited by 121
Self-citationBouet-Toussaint, F., Cabillic, F., Toutirais, O., Gallo, M. L., Pintière, C. T. D. L., Daniel, P., Genetet, N., Meunier, B., Dupont-Bierre, E., Boudjéma, K., et al. (2007) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-007-0391-3 · Cited by 114
Liu, Z., Guo, B., Gehrs, B. C., Nan, L., & Lopez, R. D. (2005) · The Journal of Urology · doi:10.1097/01.ju.0000154355.45816.0b · Cited by 103
Toren, A., Bielorai, B., Jacob‐Hirsch, J., Fisher, T., Kreiser, D., Moran, O., Zeligson, S., Givol, D., Yitzhaky, A., Itskovitz‐Eldor, J., et al. (2005) · Stem Cells · doi:10.1634/stemcells.2004-0317 · Cited by 94
Harwood, H., Alvarez, I. M., Noyes, W. D., et al. (1991) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41954-6 · Cited by 72
Catellani, S., Poggi, A. D., Bruzzone, A., Dadati, P., Ravetti, J. L., Gobbi, M., & Zocchi, M. R. (2006) · Blood · doi:10.1182/blood-2006-06-028985 · Cited by 59
Whitehead, R. P., Lew, D. L., Flanigan, R. C., Weiss, G. R., Roy, V., Glodé, M., Dakhil, S. R., & Crawford, E. D. (2002) · Journal of Immunotherapy · doi:10.1097/00002371-200207000-00007 · Cited by 53
A novel assay for assessment of HIV‐specific cytotoxicity by multiparameter flow cytometry
Godoy‐Ramirez, K., Mäkitalo, B., Thorstensson, R., Sandström, E., Biberfeld, G., & Gaines, H. (2005) · Cytometry Part A · doi:10.1002/cyto.a.20189 · Cited by 48
Mattarollo, S. R., Kenna, T., Nieda, M., & Nicol, A. J. (2006) · International Journal of Cancer · doi:10.1002/ijc.22019 · Cited by 48
Selin, L. K., STEWART, S., Shen, C., MAO, H. Q., & Wilkins, J. A. (1992) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1992.tb02946.x · Cited by 48
Viey, E., Lucas, C., Romagné, F., Escudier, B. J., Chouaïb, S., & Caignard, A. (2008) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3181609988 · Cited by 47
Interleukin‐4 induces human hepatocyte apoptosis through a Fas‐independent pathway
Aoudjehane, L., Podevin, P., Scatton, O., Jaffray, P., Dusanter‐Fourt, I., Feldmann, G., Massault, P. P., Grira, L., Bringuier, A. F., Dousset, B. E., et al. (2007) · The FASEB Journal · doi:10.1096/fj.06-6319com · Cited by 47
Recognition of nonpeptide antigens by T cells
Tanaka, Y., Brenner, M. B., Bloom, B. R., & Morita, C. T. (1996) · Journal of Molecular Medicine · doi:10.1007/bf00196576 · Cited by 36
Falkensammer, C. E., Jöhrer, K., Gander, H., Ramoner, R. E., Putz, T., Rahm, A., Greil, R., Bartsch, G. H., & Thurnher, M. (2006) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-006-0122-1 · Cited by 35
Watanabe, N., HIZUTA, A., Tanaka, N., & Orita, K. (1995) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1995.tb06651.x · Cited by 28
Perforin-dependent killing of tumor cells by Vγ1Vδ1-bearing T-cells
Narazaki, H., Watari, E., Shimizu, M., Owaki, A., Das, H., Fukunaga, Y., Takahashi, H., & Sugita, M. (2003) · Immunology Letters · doi:10.1016/s0165-2478(02)00292-4 · Cited by 18
Cited by
Cancer stem cells: advances in knowledge and implications for cancer therapy
Chu, X., Tian, W., Ning, J., Xiao, G., Zhou, Y., Wang, Z., Zhai, Z., Tanzhu, G., Yang, J., & Zhou, R. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01851-y · Cited by 553
Colon Cancer Stem Cells: Promise of Targeted Therapy
Todaro, M., Francipane, M. G., Medema, J. P., & Stassi, G. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.12.063 · Cited by 443
Self-citationBaek, A. E., Yu, Y.-R. A., He, S., Wardell, S. E., Chang, C.-Y., Kwon, S., Pillai, R. V., McDowell, H. B., Thompson, J. W., Dubois, L. G., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00910-z · Cited by 427
γδ T cells: pleiotropic immune effectors with therapeutic potential in cancer
Silva-Santos, B., Mensurado, S., & Coffelt, S. B. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0153-5 · Cited by 425
γδ T Cells Support Pancreatic Oncogenesis by Restraining αβ T Cell Activation
Daley, D., Zambirinis, C. P., Seifert, L., Akkad, N., Mohan, N., Werba, G., Barilla, R., Torres-Hernandez, A., Hundeyin, M., Mani, V. R. K., et al. (2016) · Cell · doi:10.1016/j.cell.2016.07.046 · Cited by 329
Metadata
- Authors
- Todaro, M., D'Asaro, M., Caccamo, N., Iovino, F., Francipane, M. G., Meraviglia, S., Orlando, V., La Mendola, C., Gulotta, G., Salerno, A., Dieli, F., & Stassi, G.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-06-01
- Volume
- 182
- Issue
- 11
- Pages
- 7287-7296
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1674967027
- Cited by
- 280
- References
- 58
- FWCI
- 8.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.